Article
Highly sensitised patients awaiting deceased donor renal transplants are disadvantaged by the presence of denatured HLA antibody detected in routine HLA antibody testing.
HLA - 1 Jul 2022
Battle Richard K, Rennie Trijntje J W, Phelan Paul J, Abel Angela A, McConnell Sylvia, Turner David M
Abstract excerpt
Luminex single antigen bead (SAB) assays used to detect HLA antibodies may artificially increase sensitisation in highly sensitised patients (HSP). The presence of denatured HLA (dHLA) within the assay enables antibodies specific to cryptic HLA epitopes to bind, such antibodies are not clinically relevant. We sought to exclude dHLA reactivity in a cohort of very HSP, calculated reaction frequency (cRF) 95%-100%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
